Skip to content
healthcare.dev

Byooviz

NDC 82667-018, ranibizumab-nuna, injection, solution, from Harrow Eye, LLC.

Product NDC
82667-018
Status
Listed
Labeler
Harrow Eye, LLC
Dosage form
INJECTION, SOLUTION
Route
INTRAVITREAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761202
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/82667-018 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RANIBIZUMAB10 mg/mL

Pharmacologic classes

Vascular Endothelial Growth Factor Inhibitor [EPC]; Vascular Endothelial Growth Factor Inhibitors [MoA]

Package NDCNDC-11Package
82667-018-05826670018051 VIAL, SINGLE-DOSE in 1 CARTON (82667-018-05) / .05 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/77b53b2c-da0e-44b2-ade4-b08ff75a7584
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=82667-018

Use it

Look up 82667-018 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/82667-018 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 82667-018. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.